PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
PharmaCyte Biotech, Inc. (PMCB)
NASDAQ:AMEX Investor Relations:
ir.pharmacytebiotech.com
Company Research
Source: Business Wire
LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced the successful monetization of its stake in Femasys Inc. (NASDAQ: FEMY), further validating the Company’s strategic approach to capital deployment and strengthening its already solid financial position.Following the monetization of the stake, PharmaCyte’s cash and marketable securities are expected to increase to approximately $20 million, up from $13.3 million as of July 31, 2025. This transaction highlights the Company’s ability to identify and execute on high-quality opportunities that deliver strong returns while maintaining a conservative risk profile.“Our successful monetization of the Femasys position demonstrates the effectiveness of our strategic and disciplined capital allocation approach,” said Josh Silverman, PharmaCyte Chief Executive Officer. “We are committed to deploying shareholder capital intelligently, balancing near-term returns with opportunities
Show less
Read more
Impact Snapshot
Event Time:
PMCB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PMCB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PMCB alerts
High impacting PharmaCyte Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
PMCB
Sec Filings
- 12/5/25 - Form 8-K
- 11/18/25 - Form 8-K/A
- 11/7/25 - Form SCHEDULE
- PMCB's page on the SEC website